Marcylene Vieira da Silveira

Mrs. Marcylene Vieira da Silveira

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
BBBIANCA FAGAN BISSACOTTI
BIANCA FAGAN BISSACOTTI
Marcylene Vieira da SilveiraMarcylene Vieira da Silveira
Marcylene Vieira da Silveira
CACharles Elias Assmann
Charles Elias Assmann
PCPriscila Marquezan Copetti
Priscila Marquezan Copetti
ASAndré Flores dos Santos
André Flores dos Santos
ASALEKSANDRO S.Da Silva
ALEKSANDRO S.Da Silva
Background/Objectives: Chronic inflammation and inappropriate NLRP3 inflammasome regulation are related to many brain diseases. Purinergic mediators may play an important role in inflammation regulation and could be targeted for effective therapies for these illnesses. We evaluated resveratrol’s anti-neuroinflammatory potential in BV-2 microglia cells using an innovative in vitro method of NLRP3 inflammasome activation, correlating with the P2X7 purinergic receptor. Methods: In silico analyses were used to estimate resveratrol’s interaction with NLRP3, and its cytotoxicity was measured for 24, 48, and 72 h. Moreover, microglia were exposed to lipopolysaccharide and nigericin to activate the NLRP3 inflammasome and treated with resveratrol between these inflammatory agents. Results: It was found that resveratrol has binding compatible with modulating NLRP3. Specifically, 0.1–25 µM of resveratrol presented a favorable safety profile in BV-2 cells. Microglia exposed to the inflammatory agents had increased levels of oxidative species, the P2X7 receptor, and pro-inflammatory cytokines. However, resveratrol decreased the NLRP3, caspase-1, IL-1β, IL-6, and TNF-α mRNA levels and protein density; on the other hand, IL-10 was increased, acting as a protector, preventing exacerbated inflammation. Under resveratrol exposure, P2X7 was negatively expressed, regulating inflammation to establish homeostasis and microglial proliferation. Additionally, resveratrol activates the A1 adenosine receptor, possibly correlated with neuroprotective effects. Conclusions: We confirmed the anti-neuroinflammatory action of resveratrol via the P2X7 receptor and NLRP3’s combined modulation, regulating the cell cycle and reducing pro-inflammatory and oxidant agents. Considering this pathway, resveratrol could be a candidate for further investigations as a potential treatment against neuroinflammatory diseases.

12 January 2026 in Purinergic Signalling
Verified
Journal Article
Open access
PDF file
BRBianca Vedoin Copês Rambo
Bianca Vedoin Copês Rambo
MCMilagros Fanny Vera Castro
Milagros Fanny Vera Castro
MSMairin Schott
Mairin Schott
RSRobson Lourenço da Silva Santos
Robson Lourenço da Silva Santos
CACharles Elias Assmann
Charles Elias Assmann
VMVera Maria Melchiors Morsch
Vera Maria Melchiors Morsch
Microglial activation drives neuroinflammation, a key factor in many neurological diseases. The purinergic system is a major regulator of inflammatory responses and represents a promising target for controlling neuroinflammation. Capsaicin, a bioactive compound found in chili peppers, exhibits significant anti-inflammatory and antioxidant properties. This study aimed to investigate the modulatory effects of capsaicin on microglial activation and purinergic system regulation. For this, BV-2 microglial cells were exposed to lipopolysaccharide (1 μg/mL) and treated with capsaicin (25 and 50 μM) for 24 hours. Cell viability was assessed by MTT and trypan blue assays. Cell cycle and apoptosis were evaluated by flow cytometry. Nitric oxide, reactive species and malondialdehyde levels were evaluated as markers of oxidative stress. Activities of NTPDase, 5'-nucleotidase (5’-NT), and adenosine deaminase (ADA) were evaluated. Gene expression of inflammatory mediators and purinergic receptors were analyzed by qRT-PCR, and molecular docking analyses were performed. As a result, capsaicin decreased the expression of pro-inflammatory mediators (NLRP3, CASP-1, IL-1β, IL-6, and TNF-α), increased IL-10 expression, and attenuated oxidative stress. It reduced NTPDase, 5'-NT, and ADA activities, downregulated P2X7 and A2A receptor expression, and upregulated A1 receptor expression. Molecular docking revealed that capsaicin has a high affinity for the A1 and A2A receptors, as well as for ADA. Collectively, these findings suggest that capsaicin exerts neuroprotective effect by suppressing pro-inflammatory signaling, enhancing anti-inflammatory responses, reducing oxidative stress, and modulating key components of the purinergic system, including ectoenzyme activities and P2X7, A1, and A2A receptor expression. Graphical Abstract Lipopolysaccharide (LPS) activates microglia via the NLRP3 pathway, increasing pro-inflammatory cytokines, purinergic receptors expression (P2X7 and A2A), and the activity of CD39, CD73, and ADA. Capsaicin mitigates this inflammatory profile by inhibiting NLRP3 signaling, reducing pro-inflammatory cytokine expression and modulating purinergic signaling toward an anti-inflammatory profile. Illustrations were obtained from Servier Medical Art ( https://smart.servier.com/ ), licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).

17 February 2024 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
MCMilagros Fanny Vera Castro
Milagros Fanny Vera Castro
CACharles Elias Assmann
Charles Elias Assmann
KRKarine Paula Reichert
Karine Paula Reichert
PCPriscila Marquezan Copetti
Priscila Marquezan Copetti
NSNaiara Stefanello
Naiara Stefanello
MSMARIA ROSA CHITOLINA Schetinger
MARIA ROSA CHITOLINA Schetinger

28 January 2025 in Life
Verified
Journal Article
Open access
PDF file
LSLuisa Chitolina Schetinger
Luisa Chitolina Schetinger
LJLoren S. B. de Jesus
Loren S. B. de Jesus
NBNathieli B. Bottari
Nathieli B. Bottari
AVAltevir Rossato Viana
Altevir Rossato Viana
JNJelson N. Nauderer
Jelson N. Nauderer
MSMARIA ROSA CHITOLINA Schetinger
MARIA ROSA CHITOLINA Schetinger
Cutaneous melanoma (CM) is an aggressive and metastatic tumor, resulting in high mortality rates. Despite significant advances in therapeutics, the available treatments still require improvements. Thus, purinergic signaling emerged as a potential pathway to cancer therapy due to its involvement in cell communication, proliferation, differentiation, and apoptosis. In addition, due to safety and acceptable clinical tolerability, carotenoids from microalgae have been investigated as adjuvants in anti-melanoma therapy. Then, this work aimed to investigate the in vitro anti-melanogenic effect of carotenoid extract (CA) and total biomass (BM) of the Scenedesmus obliquus microalgae on two cutaneous melanoma cell lines (A375 and B16F10). Cells were cultivated under ideal conditions and treated with 10, 25, 50, and 100 μM of CA or BM for 24 h. The effects of the compounds on viability, oxidant status, and purinergic signaling were verified. The IC50 cell viability results showed that CA and BM decreased B16F10 viability at 24.29 μM and 74.85 μM, respectively and decreased A375 viability at 73.93 μM and 127.80 μM, respectively. Carotenoid treatment for 24 h in B16F10 and A375 cells increased the release of reactive oxygen species compared to the control. In addition, CA and BM isolated or combined with cisplatin chemotherapy (CIS) modulated the purinergic system in B16F10 and A375 cell lines through P2X7, A2AR, CD39, and 5′-nucleotidase. They led to cell apoptosis and immunoregulation by activating A2A receptors and CD73 inhibition. The results disclose that CA and BM from Scenedesmus obliquus exhibit an anti-melanogenic effect, inhibiting melanoma cell growth.

1 July 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
VMVitor Bastianello Mostardeiro
Vitor Bastianello Mostardeiro
CACharles Elias Assmann
Charles Elias Assmann
ASAdriel Antonio Schirmann
Adriel Antonio Schirmann
Marcylene Vieira da SilveiraMarcylene Vieira da Silveira
Marcylene Vieira da Silveira
BRBianca Vedoin Copês Rambo
Bianca Vedoin Copês Rambo
VMVera Maria Melchiors Morsch
Vera Maria Melchiors Morsch
Background/Objectives: Major depressive disorder (MDD) is a debilitating illness, and chronic stress is a contributing factor for depressive symptoms. However, despite intense research, the mechanisms of MDD remain substantially unidentified. Quercetin is a powerful flavonoid and could be used as a possible therapeutic strategy for depression. Acknowledging the potential benefits of quercetin, this study investigated its effect alone or in association with the standard drug tranylcypromine (TCP) in a rodent model of chronic restraint stress (CRS). Methods: Adult male rats were subjected to a CRS model consisting of an immobilization session of 4 h daily during 14 consecutive days. Quercetin (50 mg/kg, gavage) was administered for 45 days. TCP (10 mg/kg, gavage) was administered for 14 days. Behavioral tasks were conducted to assess locomotor functions, memory, anhedonia, depression-like behaviors, and anxiety-like behaviors. The activity, gene expression, and protein density of acetylcholinesterase (AChE) were investigated. Results: Behavioral tasks showed that the CRS model effectively induced stable behavioral changes. CRS did not alter locomotor function assessed by the open field test (OFT) or anhedonia behavior assessed by the sucrose preference test (SPT). CRS increased total fecal count, which was prevented by quercetin administration in rats. TCP and the association of quercetin and TCP increased the recognition index in comparison with the CRS group in the novel object recognition (NOR) test and improved the swimming and immobility times in comparison to stressed animals in the forced swim test (FST). All treatments were able to decrease the anxiety index assessed by the elevated plus maze (EPM) test. The activity, gene expression, and protein density of AChE were increased in the CRS model compared to control males. Overall, quercetin and TCP proved to reverse CRS-induced alterations in these parameters. Conclusions: Quercetin mitigated cognitive deficits, behavioral impairments, and neurochemical alterations induced by the CRS model, especially in association with TCP, supporting its potential as a promising therapeutic agent for depression.

21 June 2025 in Foods
Verified
Journal Article
Open access
PDF file
TNTATIELE CASAGRANDE DO NASCIMENTO
TATIELE CASAGRANDE DO NASCIMENTO
PCPatrícia Acosta Caetano
Patrícia Acosta Caetano
Marcylene Vieira da SilveiraMarcylene Vieira da Silveira
Marcylene Vieira da Silveira
Luiz Eduardo Lobo e SilvaLuiz Eduardo Lobo e Silva
Luiz Eduardo Lobo e Silva
URUashington da Silva Riste
Uashington da Silva Riste
Leila Queiroz ZepkaLeila Queiroz Zepka
Leila Queiroz Zepka
This study investigated the cecal distribution of lipophilic pigments (carotenoids and chlorophylls) from Scenedesmus obliquus and their effects on the activity of the intestinal microbiota in rats. Oleoresins containing different concentrations of microalgal pigments (from 0 to 600 µg·kg−1bw·d−1), previously characterized by chromatographic and spectrometric analyses, were administered for four weeks. At the end of the intervention, cecal content samples were collected and analyzed for their pigment composition, short-chain fatty acids (SCFAs), and probiotic microbiota. Nine pigments were identified in the cecal samples, with all-trans-zeaxanthin and pheophytin being the most abundant in all groups. Furthermore, 15-cis-lutein, all-trans-β-cryptoxanthin, and 9-cis-β-carotene—found exclusively in microalgal oleoresin—were detected only in animals receiving doses above 300 µg·kg−1bw.day−1, indicating a link with the SCFA modulation. These supplementations significantly increased the levels of acetate (300 and 450 µg·kg−1bw·d−1 −13% and 14%), butyrate (300 µg kg−1bw·d−1 −19%), and propionate (600 µg·kg−1bw·d−1 −16%). Notably, 300 µg·kg−1bw·d−1 significantly increased Bifidobacterium and Lactobacillus populations. Overall, the pigment supplementation positively influenced the gut microbiota composition and SCFA production in a dose-dependent manner, particularly at 300 µg·kg−1bw·d−1. These results support the potential application of microalgal pigments as functional food ingredients or supplements with gut health benefits.